Chin Retrusion

Pipeline Programs

Companies

Clinical Trials

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

GaldermaTX - Dallas

2 programs

Restylane DefyneN/A1 trial

Active Trials

NCT03597256Completed148Est. Sep 2020

NCT03624816Completed140Est. Feb 2020

AbbVieNORTH CHICAGO, IL

1 program

Hyaluronic Acid Injectable GelN/A1 trial

Active Trials

NCT02559908Completed120Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021

2022

2023

2024

2025

2026

GaldermaRestylane Defyne

AbbVieHyaluronic Acid Injectable Gel

Clinical Trials (3)

Total enrollment: 408 patients across 3 trials

NCT03597256 GaldermaRestylane Defyne

Restylane Defyne for Correction of Chin Retrusion

Start: Oct 2018Est. completion: Sep 2020148 patients

N/ACompleted

NCT03624816 GaldermaRestylane Defyne

A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion

Start: Aug 2018Est. completion: Feb 2020140 patients

N/ACompleted

NCT02559908 AbbVieHyaluronic Acid Injectable Gel

A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw

Start: Feb 2015Est. completion: Dec 2017120 patients

N/ACompleted

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.